Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 126,804 |
|
|||||
| News | - | ||||||
| Day High | 0.5152 | Low High |
|||||
| Day Low | 0.4919 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Panbela Therapeutics Inc | PBLA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0191 | -3.68% | 0.50 | 19:34:35 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.505 | 0.4919 | 0.5152 | 0.5107 | 0.5191 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 500 | 126,804 | $ 0.5071635 | $ 64,310 | - | 0.48 - 295.20 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:34:35 | formt | 914 | $ 0.50 | USD |
Panbela Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 17.69M | 5.13M | - | 0 | -34.93M | -6.81 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Panbela Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PBLA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.5421 | 0.65 | 0.4919 | 0.5131962 | 745,381 | -0.0421 | -7.77% |
| 1 Month | 0.8751 | 0.8751 | 0.48 | 0.5463285 | 346,137 | -0.3751 | -42.86% |
| 3 Months | 1.40 | 1.44 | 0.48 | 0.8936194 | 1,156,993 | -0.90 | -64.29% |
| 6 Months | 5.92 | 9.04 | 0.48 | 1.58 | 1,050,134 | -5.42 | -91.55% |
| 1 Year | 130.80 | 295.20 | 0.48 | 75.10 | 3,388,839 | -130.30 | -99.62% |
| 3 Years | 4,200.00 | 10,560.00 | 0.48 | 269.63 | 1,283,365 | -4,199.50 | -99.99% |
| 5 Years | 4,080.00 | 10,560.00 | 0.48 | 270.12 | 1,278,469 | -4,079.50 | -99.99% |
Panbela Therapeutics Description
| Panbela Therapeutics Inc is a clinical stage drug development company. It is engaged in the commercial development of a proprietary polyamine analogue for pancreatic cancer and for the second indication in chronic pancreatitis. The firm has developed a polyamine analogue compound referred as SBP-101 for the exocrine pancreas, with therapeutic potential for both pancreatic cancer and pancreatitis indications. |
